Technology provides non-invasive treatment for congenital heart disease patients

(Society for Cardiovascular Angiography and Interventions) New study results, presented at SCAI 2021, validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function.